Showing results (301-310 of 941) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|October 4, 2025
Improvement in Motor Consistency and Stability with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Post Hoc Analysis of Two Phase 3 Clinical TrialsRajesh Pahwa, Jason Aldred, Michael J Soileau, et al.
Neurology and Therapy|September 25, 2025
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing SurveillanceTakashi Yamamura, Noriko Isobe, Izumi Kawachi, et al.
Neurology and Therapy|July 4, 2025
Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS StudyHeinz Wiendl, Frederik Barkhof, Xavier Montalban, et al.
Neurology and Therapy|December 25, 2025
Informant-Based Questionnaires in the Diagnostic Pathway for Screening of Cognitive ImpairmentAbarajithan Chandrasekaran, Michael Malek-Ahmadi, Boris Decourt, et al.
Neurology and Therapy|December 18, 2025
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment PlansPeter J Goadsby, Alexandra J Sinclair, Shazia K Afridi, et al.
Neurology and Therapy|December 17, 2025
Real-World Experience with Anti-CGRP Pathway Monoclonal Antibodies in a Large United States Healthcare Plan: Results of the Migraine Signature StudyDawn C Buse, Richard B Lipton, Robert Urman, et al.
Neurology and Therapy|April 2, 2025
Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative ReviewJuliana West, Maggie Li, Sabrina Wong, et al.
Neurology and Therapy|April 6, 2025
The Kappa Free Light Chains Index and Central Vein Sign: Two New Biomarkers for Multiple Sclerosis DiagnosisMichael Levraut, Cassandre Landes-Chateau, Lydiane Mondot, et al.
Neurology and Therapy|May 11, 2025
The Modified Functional Status Questionnaire for Assessing Patients with Parkinson's Disease Psychosis Treated with Pimavanserin: A Post Hoc AnalysisVirgilio G H Evidente, Lambros Chrones, Ratna Revankar, et al.
Neurology and Therapy|May 3, 2025
Efficacy of Stiripentol Beyond Dravet Syndrome: A Retrospective Medical Record Review of Patients with Drug-Resistant EpilepsiesVíctor Soto-Insuga, Elena González-Alguacil, María Ballarà-Petitbò, et al.
Pageof 95